Logo image of ALGTR.PA

GROUPE TERA (ALGTR.PA) Stock Fundamental Analysis

EPA:ALGTR - Euronext Paris - Matif - FR0013429404 - Common Stock - Currency: EUR

5.1  +0.1 (+2%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to ALGTR. ALGTR was compared to 50 industry peers in the Electronic Equipment, Instruments & Components industry. The financial health of ALGTR is average, but there are quite some concerns on its profitability. ALGTR has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year ALGTR has reported negative net income.
In the past year ALGTR had a positive cash flow from operations.
In the past 5 years ALGTR reported 4 times negative net income.
In the past 5 years ALGTR reported 4 times negative operating cash flow.
ALGTR.PA Yearly Net Income VS EBIT VS OCF VS FCFALGTR.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 1M -1M 2M -2M

1.2 Ratios

ALGTR has a worse Return On Assets (-3.66%) than 66.00% of its industry peers.
With a Return On Equity value of -29.96%, ALGTR is not doing good in the industry: 72.00% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -3.66%
ROE -29.96%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ALGTR.PA Yearly ROA, ROE, ROICALGTR.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

1.3 Margins

ALGTR's Gross Margin of 88.49% is amongst the best of the industry. ALGTR outperforms 100.00% of its industry peers.
In the last couple of years the Gross Margin of ALGTR has remained more or less at the same level.
The Profit Margin and Operating Margin are not available for ALGTR so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 88.49%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.43%
GM growth 5Y0.31%
ALGTR.PA Yearly Profit, Operating, Gross MarginsALGTR.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

More info and screens

5

2. Health

2.1 Basic Checks

ALGTR does not have a ROIC to compare to the WACC, probably because it is not profitable.
ALGTR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
ALGTR.PA Yearly Shares OutstandingALGTR.PA Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 1M 2M 3M
ALGTR.PA Yearly Total Debt VS Total AssetsALGTR.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 5M 10M 15M

2.2 Solvency

Based on the Altman-Z score of 1.26, we must say that ALGTR is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of ALGTR (1.26) is worse than 72.00% of its industry peers.
The Debt to FCF ratio of ALGTR is 4.71, which is a neutral value as it means it would take ALGTR, 4.71 years of fcf income to pay off all of its debts.
ALGTR has a Debt to FCF ratio of 4.71. This is in the better half of the industry: ALGTR outperforms 66.00% of its industry peers.
A Debt/Equity ratio of 4.52 is on the high side and indicates that ALGTR has dependencies on debt financing.
ALGTR has a worse Debt to Equity ratio (4.52) than 88.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 4.52
Debt/FCF 4.71
Altman-Z 1.26
ROIC/WACCN/A
WACC7.94%
ALGTR.PA Yearly LT Debt VS Equity VS FCFALGTR.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M 6M

2.3 Liquidity

A Current Ratio of 2.28 indicates that ALGTR has no problem at all paying its short term obligations.
The Current ratio of ALGTR (2.28) is better than 74.00% of its industry peers.
A Quick Ratio of 2.12 indicates that ALGTR has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 2.12, ALGTR belongs to the top of the industry, outperforming 92.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.28
Quick Ratio 2.12
ALGTR.PA Yearly Current Assets VS Current LiabilitesALGTR.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2M 4M 6M 8M 10M

More info and screens

6

3. Growth

3.1 Past

ALGTR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 61.77%, which is quite impressive.
ALGTR shows a small growth in Revenue. In the last year, the Revenue has grown by 0.25%.
Measured over the past years, ALGTR shows a very strong growth in Revenue. The Revenue has been growing by 23.41% on average per year.
EPS 1Y (TTM)61.77%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%19.83%
Revenue 1Y (TTM)0.25%
Revenue growth 3Y3.14%
Revenue growth 5Y23.41%
Sales Q2Q%12.29%

3.2 Future

Based on estimates for the next years, ALGTR will show a very strong growth in Earnings Per Share. The EPS will grow by 835.79% on average per year.
Based on estimates for the next years, ALGTR will show a quite strong growth in Revenue. The Revenue will grow by 18.42% on average per year.
EPS Next Y3900%
EPS Next 2Y835.79%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year18.13%
Revenue Next 2Y18.42%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
ALGTR.PA Yearly Revenue VS EstimatesALGTR.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 5M 10M 15M 20M
ALGTR.PA Yearly EPS VS EstimatesALGTR.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 0 0.2 -0.2 0.4 0.6 0.8

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

ALGTR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
With a Price/Forward Earnings ratio of 13.03, ALGTR is valued correctly.
Based on the Price/Forward Earnings ratio, ALGTR is valued a bit cheaper than 68.00% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.19, ALGTR is valued a bit cheaper.
Industry RankSector Rank
PE N/A
Fwd PE 13.03
ALGTR.PA Price Earnings VS Forward Price EarningsALGTR.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ALGTR indicates a slightly more expensive valuation: ALGTR is more expensive than 62.00% of the companies listed in the same industry.
76.00% of the companies in the same industry are more expensive than ALGTR, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 9.07
EV/EBITDA 27.66
ALGTR.PA Per share dataALGTR.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ALGTR's earnings are expected to grow with 835.79% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y835.79%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

ALGTR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

GROUPE TERA

EPA:ALGTR (6/18/2025, 7:00:00 PM)

5.1

+0.1 (+2%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.57%
Inst Owner ChangeN/A
Ins Owners7.36%
Ins Owner ChangeN/A
Market Cap20.55M
Analysts84.44
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 13.03
P/S 1.6
P/FCF 9.07
P/OCF 9.07
P/B 8.71
P/tB N/A
EV/EBITDA 27.66
EPS(TTM)-0.2
EYN/A
EPS(NY)0.39
Fwd EY7.67%
FCF(TTM)0.56
FCFY11.03%
OCF(TTM)0.56
OCFY11.03%
SpS3.2
BVpS0.59
TBVpS-0.35
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3.66%
ROE -29.96%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 88.49%
FCFM 17.59%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.43%
GM growth 5Y0.31%
F-Score5
Asset Turnover0.67
Health
Industry RankSector Rank
Debt/Equity 4.52
Debt/FCF 4.71
Debt/EBITDA 11.46
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion 243.39%
Profit Quality N/A
Current Ratio 2.28
Quick Ratio 2.12
Altman-Z 1.26
F-Score5
WACC7.94%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)61.77%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%19.83%
EPS Next Y3900%
EPS Next 2Y835.79%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)0.25%
Revenue growth 3Y3.14%
Revenue growth 5Y23.41%
Sales Q2Q%12.29%
Revenue Next Year18.13%
Revenue Next 2Y18.42%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-6.42%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year508.76%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y456.29%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y456.29%
OCF growth 3YN/A
OCF growth 5YN/A